Lars Bastholtd

发表

A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma . Results of the Danish Head and Neck Cancer Study ( DAHANCA ) Protocol 585

Jens Overgaarda, Hanne Sand Hansenb, Marie Overgaardc, 1998 .